D F Schafer, M F Sorrell. Show Affiliations »
Abstract
Mesh: See more » Antiviral Agents/adverse effectsAntiviral Agents/therapeutic useDrug Administration ScheduleGenotypeHepacivirus/geneticsHepatitis C, Chronic/drug therapyHumansInterferon alpha-2Interferon-alpha/adverse effectsInterferon-alpha/therapeutic usePolyethylene Glycols/adverse effectsPolyethylene Glycols/therapeutic useRecombinant Proteins
Substances: See more » Antiviral AgentsInterferon alpha-2Interferon-alphaRecombinant ProteinsPolyethylene Glycolspeginterferon alfa-2a
Year: 2000 PMID: 11106723 DOI: 10.1056/NEJM200012073432309
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245